person · Reporting owner
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Milestone Pharmaceuticals Inc.
Report date July 28, 2020 · Filed July 30, 2020
Section 16 reporting ended · disclosed 2020-07-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common sharesSEC Table I · non-derivative | Direct | 2,254,920 |
Ending reported balance
After 2020-07-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-07-28 · Sale · Disposed 19,863 · Balance 2,754,920 Row 2 · 2020-07-29 · Sale · Disposed 500,000 · Balance 2,254,920 |
enGene Therapeutics Inc.
Report date April 18, 2024 · Filed April 22, 2024
Section 16 reporting ended · disclosed 2024-04-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common sharesSEC Table I · non-derivative | Direct | 3,036,153 |
Ending reported balance
After 2024-04-22 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-04-18 · Sale · Disposed 4,575 · Balance 3,084,107 Row 2 · 2024-04-19 · Sale · Disposed 100 · Balance 3,084,007 Row 3 · 2024-04-22 · Sale · Disposed 47,854 · Balance 3,036,153 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 22, 2024 Filed Apr 22, 2024 17:22 UTC | enGene Therapeutics Inc. ENGN · Entity 6638 | SaleCommon shares | 47,854 | $15.00 | $717,810.00 |
DisclosureSEC source: 0000950142-24-001171 · es240472025_4-engn.xml · nonDerivative · entry 3 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,036,153 Read SEC document |
| April 19, 2024 Filed Apr 22, 2024 17:22 UTC | enGene Therapeutics Inc. ENGN · Entity 6638 | SaleCommon shares | 100 | $15.00 | $1,500.00 |
DisclosureSEC source: 0000950142-24-001171 · es240472025_4-engn.xml · nonDerivative · entry 2 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,084,007 Read SEC document |
| April 18, 2024 Filed Apr 22, 2024 17:22 UTC | enGene Therapeutics Inc. ENGN · Entity 6638 | SaleCommon shares | 4,575 | $15.01 | $68,670.75 |
DisclosureSEC source: 0000950142-24-001171 · es240472025_4-engn.xml · nonDerivative · entry 1 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,084,107 Read SEC document |
| July 29, 2020 Filed Jul 30, 2020 19:43 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | SaleCommon shares | 500,000 | $8.32 | $4,160,000.00 |
DisclosureSEC source: 0000950142-20-001849 · es2000983_4-fonds.xml · nonDerivative · entry 2 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,254,920 Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 19:43 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | SaleCommon shares | 19,863 | $8.10 | $160,890.30 |
DisclosureSEC source: 0000950142-20-001849 · es2000983_4-fonds.xml · nonDerivative · entry 1 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,754,920 Read SEC document |
| May 13, 2019 Filed May 15, 2019 14:49 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | ConversionSeries D-1 Preferred · Derivative | 306,092 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-19-001098 · es1900658_4-fonds.xml · derivative · entry 11 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 306,092 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. Read SEC document |
| May 13, 2019 Filed May 15, 2019 14:49 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | ConversionSeries C Preferred · Derivative | 437,203 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-19-001098 · es1900658_4-fonds.xml · derivative · entry 10 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 437,203 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. Read SEC document |
| May 13, 2019 Filed May 15, 2019 14:49 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | ConversionSeries B Preferred · Derivative | 574,292 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-19-001098 · es1900658_4-fonds.xml · derivative · entry 9 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 574,292 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. Read SEC document |
| May 13, 2019 Filed May 15, 2019 14:49 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | ConversionSeries A-2 Preferred · Derivative | 798,974 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-19-001098 · es1900658_4-fonds.xml · derivative · entry 8 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 798,974 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. Read SEC document |
| May 13, 2019 Filed May 15, 2019 14:49 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | ConversionSeries A-1 Preferred · Derivative | 139,849 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-19-001098 · es1900658_4-fonds.xml · derivative · entry 7 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 139,849 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. Read SEC document |
| May 13, 2019 Filed May 15, 2019 14:49 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | PurchaseCommon Shares | 433,333 | $15.00 | $6,499,995.00 |
DisclosureSEC source: 0000950142-19-001098 · es1900658_4-fonds.xml · nonDerivative · entry 6 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,720,310 Read SEC document |
| May 13, 2019 Filed May 15, 2019 14:49 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | ConversionCommon Shares | 306,092 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-19-001098 · es1900658_4-fonds.xml · nonDerivative · entry 5 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,286,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. Read SEC document |
| May 13, 2019 Filed May 15, 2019 14:49 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | ConversionCommon Shares | 437,203 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-19-001098 · es1900658_4-fonds.xml · nonDerivative · entry 4 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,980,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. Read SEC document |
| May 13, 2019 Filed May 15, 2019 14:49 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | ConversionCommon Shares | 574,292 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-19-001098 · es1900658_4-fonds.xml · nonDerivative · entry 3 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,543,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. Read SEC document |
| May 13, 2019 Filed May 15, 2019 14:49 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | ConversionCommon Shares | 798,974 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-19-001098 · es1900658_4-fonds.xml · nonDerivative · entry 2 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 969,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. Read SEC document |
| May 13, 2019 Filed May 15, 2019 14:49 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | ConversionCommon Shares | 139,849 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-19-001098 · es1900658_4-fonds.xml · nonDerivative · entry 1 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC · CIK 0000903337 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.